{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:44:39Z","timestamp":1776001479295,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03103","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T23:15:48Z","timestamp":1548717348000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity"],"prefix":"10.3389","volume":"9","author":[{"given":"Sietske K.","family":"Rosendahl Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald H. J.","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"van de Kassteele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanda C.","family":"Mandersloot-Oskam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e A. J.","family":"van Boxtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M. J.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"Luytjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josine","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"B1","unstructured":"Fact Sheet Seasonal Influenza2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002082","DOI":"10.1371\/journal.pbio.1002082","article-title":"Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data","author":"Kucharski","year":"2015","journal-title":"PLoS Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","article-title":"Virus-specific T cells as correlate of (cross-)protective immunity against influenza","volume":"33","author":"Altenburg","year":"2015","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3201\/eid1906.121478","article-title":"Pandemic influenza planning, United States, 1978-2008","volume":"19","author":"Iskander","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/bsp.2010.0043","article-title":"Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations","volume":"8","author":"Rambhia","year":"2010","journal-title":"Biosecur Bioterror."},{"key":"B9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.vaccine.2011.11.092","article-title":"Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean","volume":"30","author":"Ropero-Alvarez","year":"2012","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00103-012-1582-4","article-title":"The 2009 influenza A (H1N1) pandemic. Management and vaccination strategies in The Netherlands","volume":"56","author":"van der Sande","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med."},{"key":"B12","unstructured":"High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland19478\n            IkonenN\n            StrengellM\n            KinnunenL\n            OsterlundP\n            PirhonenJ\n            BromanM\n          20144443Euro Surveill2010"},{"key":"B13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/irv.12074","article-title":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries","volume":"7","author":"Van Kerkhove","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1172\/JCI32460","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1038\/ncomms7833","article-title":"Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells","author":"Wang","year":"2015","journal-title":"Nat Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 - an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1073\/pnas.0813390106","article-title":"Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e95496","DOI":"10.1371\/journal.pone.0095496","article-title":"Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization","author":"Khurana","year":"2014","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection","volume":"6","author":"O'Hagan","year":"2007","journal-title":"Exp Rev Vaccines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-3-540-92165-3_16","article-title":"Adjuvants for pandemic influenza vaccines","volume":"333","author":"Atmar","year":"2009","journal-title":"Curr Top Microbiol Immunol."},{"key":"B26","year":"2009","journal-title":"Vaccination Against Pandemic Influenza A\/H1N1 2009: Dosage"},{"key":"B27","first-page":"321","article-title":"Proefonderzoek naar de frequentie en de aetiologie van griepachtige ziekten in de winter 1963-1964","author":"Pel","year":"1965","journal-title":"Huisarts en Wetenschap"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1016\/j.vaccine.2012.05.060","article-title":"HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains","volume":"30","author":"Luytjes","year":"2012","journal-title":"Vaccine"},{"key":"B29","unstructured":"Immunity Following Influenza Disease and Administration of Influenza Vaccines2018"},{"key":"B30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jim.2005.03.010","article-title":"Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay","volume":"305","author":"Periwal","year":"2005","journal-title":"J Immunol Methods"},{"key":"B31","volume-title":"Data Analysis Using Regression and Multileve\/Hierarchical Models.","author":"Gelman","year":"2007"},{"key":"B32","volume-title":"Models for Discrete Longitudinal Data","author":"Molenberghs","year":"2005"},{"key":"B33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","article-title":"Approximate bayesian inference for latent gaussian models using integrated nested laplace approximations (with discussion)","volume":"71","author":"Rue","year":"2009","journal-title":"J R Stat Soc B"},{"key":"B34","volume-title":"R: A Language and Environment for Statistical Computing.","year":"2013"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0264-410X(02)00632-1","article-title":"Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A\/Duck\/Singapore\/97 vaccine in a primed human population","volume":"21","author":"Stephenson","year":"2003","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"Stephenson","year":"2005","journal-title":"J Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1161","DOI":"10.1542\/peds.2010-1920","article-title":"Influenza A\/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months","volume":"127","author":"Esposito","year":"2011","journal-title":"Pediatrics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/QAD.0b013e328341afa8","article-title":"Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A\/H1N1v influenza vaccine in HIV-1-infected individuals","volume":"25","author":"Kajaste-Rudnitski","year":"2011","journal-title":"AIDS"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1016\/j.vaccine.2012.03.017","article-title":"A randomized clinical trial to identify the optimal antigen and MF59((R)) adjuvant dose of a monovalent A\/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects","volume":"30","author":"Hatz","year":"2012","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e00553","DOI":"10.1128\/CVI.00553-16","article-title":"Long-term persistence of cell-mediated and humoral responses to A(H1N1)pdm09 influenza virus vaccines and the role of the AS03 adjuvant system in adults during two randomized controlled trials","author":"van der Most","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1016\/j.vaccine.2010.10.077","article-title":"Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination","volume":"28","author":"Subbramanian","year":"2010","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1097\/INF.0b013e318255e443","article-title":"T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine","volume":"31","author":"Lambe","year":"2012","journal-title":"Pediatr Infect Dis J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1084\/jem.171.3.801","article-title":"Naive and memory T cells show distinct pathways of lymphocyte recirculation","volume":"171","author":"Mackay","year":"1990","journal-title":"J Exp Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S1074-7613(04)00103-7","article-title":"Dynamics of blood-borne CD8 memory T cell migration in vivo","volume":"20","author":"Klonowski","year":"2004","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nri1869","article-title":"Tissue-tropic effector T cells: generation and targeting opportunities","volume":"6","author":"Agace","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e85832","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.1128\/JVI.05213-11","article-title":"Annual vaccination against influenza virus hampers development of virus-specific CD8(+) T cell immunity in children","volume":"85","author":"Bodewes","year":"2011","journal-title":"J Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1016\/j.vaccine.2005.01.080","article-title":"Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults","volume":"23","author":"McElhaney","year":"2005","journal-title":"Vaccine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1099\/vir.0.048652-0","article-title":"Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses","volume":"94","author":"Hillaire","year":"2013","journal-title":"J Gen Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e91273","DOI":"10.1371\/journal.pone.0091273","article-title":"Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses","author":"Duvvuri","year":"2014","journal-title":"PLoS ONE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1073\/pnas.1322229111","article-title":"Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities","volume":"111","author":"Quinones-Parra","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e87962","DOI":"10.1371\/journal.pone.0087962","article-title":"Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine","author":"Rudenko","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T23:15:59Z","timestamp":1548717359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2018.03103"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03103","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"article-number":"3103"}}